Hsf1 Protein Heat Shock Factor 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Parameter | Value |
|-----------|-------|
| **Protein Name** | Heat Shock Factor 1 |
| **Gene** | HSF1 |
| **UniProt ID** | Q00613 |
| **PDB ID** | 5D5U, 5N5W |
| **Molecular Weight** | 53 kDa |
| **Subcellular Localization** | Cytoplasm (inactive), Nucleus (active) |
| **Protein Family** | HSF family |
The HSF1 protein is a transcription factor that serves as the master regulator of the cellular heat shock response. It controls the expression of heat shock proteins (HSPs) and other genes involved in protein homeostasis, cellular protection, and stress resistance.
HSF1 contains several functional domains:
- N-terminal DNA-binding domain (DBD): Binds to Heat Shock Elements (HSEs) in target gene promoters
- Oligomerization domain (OD): Mediates trimer formation
- Regulatory domain (RD): Contains serine phosphorylation sites and regulatory elements
- C-terminal transcription activation domain (TAD): Interacts with transcriptional coactivators
The protein exists as an inactive monomer in unstressed cells, bound to HSP90. Upon stress, HSF1 trimerizes and translocates to the nucleus.
Under normal conditions, HSF1:
- Maintains basal expression of certain chaperones
- Regulates developmental processes
- Controls stress-responsive gene networks
- Modulates inflammation and immunity
Upon proteotoxic stress:
- Rapid trimerization and nuclear translocation
- Binding to Heat Shock Elements (HGA-rich sequences)
- Recruitment of transcriptional coactivators (p300/CBP, MED1)
- Activation of HSP gene transcription
- HSF1 activity declines with aging and AD progression
- Reduced HSF1 leads to impaired Aβ clearance
- HSF1 activation can reduce amyloid burden in models
- Protects against α-synuclein toxicity
- HSF1 activators reduce dopaminergic neuron loss
- Implicated in LRRK2-associated neurodegeneration
- Counteracts aggregation of mutant SOD1, TDP-43, FUS
- HSF1 activity is compromised in ALS models
- Therapeutic potential for protein aggregation diseases
| Approach |
Compound |
Status |
| HSF1 activators |
17-AAG (tanespimycin) |
Clinical trials (cancer) |
| HSF1 activators |
17-DMAG (alvespimycin) |
Clinical trials |
| HSF1 activators |
Quercetin |
Preclinical |
| HSF1 activators |
Celastrol |
Preclinical |
Challenges: HSF1 activation may promote tumor growth in cancer patients. Careful dosing and targeted delivery needed.
- Neef DW, et al. (2010). The heat shock factor 1 and HSP70 in neurodegeneration. J Mol Neurosci 40(1-2):138-52.
- Fujimoto M, Nakai A. (2010). The heat shock factor family. FEBS J 277(21):4112-25.
- Calamini B, et al. (2012). Small-molecule proteostasis regulators. Nat Chem Biol 8(2):185-96.
The study of Hsf1 Protein Heat Shock Factor 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Akerfelt M, Morimoto RI, Sistonen L. Heat shock factors: integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol. 2010;11(8):545-555. PMID:20628474
- Westerheide SD, Bosman JD, Mbadugha BN, et al. Celastrols as potent inhibitors of thermally induced HSF1 transcriptional activation. J Nat Prod. 2004;67(4):604-607. PMID:15114487
- Fujimoto M, Nakai A. The heat shock factor family and adaptation to proteotoxic stress. FEBS J. 2019;286(10):1801-1814. PMID:30614568
- Neef DW, Turski ML, Thiele DJ. Modulation of the heat shock transcriptional response by a dominant negative HSF1 mutant. J Biol Chem. 2010;285(19):14498-14505. PMID:20223826
- Dai C, Whitesell L, Rogers AB, Lindquist S. Heat shock factor 1 is essential for gridsome homeostasis and cell viability. Cell. 2007;128(5):1005-1018. PMID:17350583